Steven P. Balk

30.6k citations

241 papers · 20.9k indexed · 5 hit papers · h-index 78

Impact in

Immunology top 0.1%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Pulmonary and Respiratory Medicine top 0.1%
- Prostate Cancer Treatment and Research

Papers in

Immunology 81
- Immune Cell Function and Interaction 76
- T-cell and B-cell Immunology 57
- Immunotherapy and Immune Responses 26
Pulmonary and Respiratory Medicine 123
- Prostate Cancer Treatment and Research 120

Co-authors: Glenn J. Bubley Mark A. Exley Steven A. Porcelli Mary‐Ellen Taplin Changmeng Cai Xin Yuan Richard S. Blumberg Shaoyong Chen
Journals: Cancer Research (24 papers)The Journal of Immunology (20 papers)Clinical Cancer Research (15 papers)Journal of Biological Chemistry (13 papers)Journal of Clinical Oncology (11 papers)
Partner nations: United States Japan China

In The Last Decade

Steven P. Balk

239 papers receiving 20.6k citations

Hit Papers

5 papers align trajectories log scale

Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer 2006 · 843 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2006 Cancer Research
2003 Journal of Clinical Oncology
1998 Nature
1995 New England Journal of Medicine
1993 The Journal of Experimental Medicine

Peers

Countries citing papers authored by Steven P. Balk

Since Specialization

Citations

This map shows the geographic impact of Steven P. Balk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven P. Balk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven P. Balk more than expected).

Fields of papers citing papers by Steven P. Balk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven P. Balk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven P. Balk. The network helps show where Steven P. Balk may publish in the future.

Co-authors

The 25 scholars most cited alongside Steven P. Balk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven P. Balk Line = papers co-authored together Steven P. Balk links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer Molecular Cancer Therapeutics ·Mannan Nouri, Andreas Varkaris, Maya Ridinger, Susan L. Dalrymple, Christopher M. Dennehy, John T. Isaacs, David J. Einstein, W. Nathaniel Brennen, Steven P. Balk	2024	3
2	Association of B7‐H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer Cancer ·Adrianna A. Mendes, Jiayun Lu, Harsimar Kaur, Siqun L. Zheng, Jianfeng Xu, Jessica Hicks, Adam B. Weiner, Edward M. Schaeffer, Ashley E. Ross, Steven P. Balk, Mary‐Ellen Taplin, Nathan A. Lack, Emirhan Tekoglu, Janielle P. Maynard, Angelo M. De Marzo, Emmanuel S. Antonarakis, Karen S. Sfanos, Corinne E. Joshu, Eugene Shenderov, Tamara L. Lotan	2022	18
3	Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate Cancer Clinical Cancer Research ·Elahe A. Mostaghel, Brett T. Marck, Orpheus Kolokythas, Felix S. Chew, Evan Y. Yu, Michael T. Schweizer, Heather H. Cheng, Philip W. Kantoff, Steven P. Balk, Mary‐Ellen Taplin, Nima Sharifi, Alvin M. Matsumoto, Peter S. Nelson, Bruce Montgomery	2021	17
4	Low Abundance of Circulating Tumor DNA in Localized Prostate Cancer JCO Precision Oncology ·S. Thomas Hennigan, Shana Y. Trostel, Nicholas T. Terrigino, Olga Voznesensky, Rachel Schaefer, Nichelle C. Whitlock, Scott Wilkinson, Nicole V. Carrabba, Rayann Atway, Steven Shema, Ross Lake, Amalia Sweet, David J. Einstein, Fatima Karzai, James L. Gulley, Peter Chang, Glenn J. Bubley, Steven P. Balk, Huihui Ye, Adam G. Sowalsky	2019	49
5	Contribution of Adrenal Glands to Intratumor Androgens and Growth of Castration-Resistant Prostate Cancer Clinical Cancer Research ·Elahe A. Mostaghel, Ailin Zhang, Susana Hernández, Brett T. Marck, Xiaotun Zhang, Daniel Tamae, Heather E. Biehl, Maria Tretiakova, Jon Bartlett, John Burns, Ruth F. Dumpit, Lisa S. Ang, Alvin M. Matsumoto, T.M. Penning, Steven P. Balk, Colm Morrissey, Eva Corey, Lawrence D. True, Peter S. Nelson	2018	49
6	Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic Alterations Cancer Research ·Adam G. Sowalsky, Huihui Ye, Manoj Bhasin, Eliezer M. Van Allen, Massimo Loda, Rosina T. Lis, Laleh Montaser‐Kouhsari, Carla Calagua, Fen Ma, Joshua W. Russo, Rachel Schaefer, Olga Voznesensky, Zhenwei Zhang, Glenn J. Bubley, Bruce Montgomery, Elahe A. Mostaghel, Peter S. Nelson, Mary‐Ellen Taplin, Steven P. Balk	2018	38
7	BMX-Mediated Regulation of Multiple Tyrosine Kinases Contributes to Castration Resistance in Prostate Cancer Cancer Research ·Sen Chen, Changmeng Cai, Adam G. Sowalsky, Huihui Ye, Fen Ma, Xin Yuan, Nicholas I. Simon, Nathanael S. Gray, Steven P. Balk	2018	21
8	Tyrosine Kinase Inhibitors Increase MCL1 Degradation and in Combination with BCLXL/BCL2 Inhibitors Drive Prostate Cancer Apoptosis Clinical Cancer Research ·Seiji Arai, Oliver Jonas, Matthew A. Whitman, Eva Corey, Steven P. Balk, Sen Chen	2018	50
9	Association of Tissue Abiraterone Levels and SLCO Genotype with Intraprostatic Steroids and Pathologic Response in Men with High-Risk Localized Prostate Cancer Clinical Cancer Research ·Elahe A. Mostaghel, Eunpi Cho, Ailin Zhang, Mohammad Alyamani, Arja Kaipainen, Sean Green, Brett T. Marck, Nima Sharifi, Jonathan L. Wright, Roman Gulati, Lawrence D. True, Massimo Loda, Alvin M. Matsumoto, Daniel Tamae, Trevor N. Penning, Steven P. Balk, Philip W. Kantoff, Peter S. Nelson, Mary-Ellen Taplin, Bruce Montgomery	2017	31
10	Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide Clinical Cancer Research ·Carla Calagua, Joshua W. Russo, Yue Sun, Rachel Schaefer, Rosina T. Lis, Zhenwei Zhang, Kathleen M. Mahoney, Glenn J. Bubley, Massimo Loda, Mary‐Ellen Taplin, Steven P. Balk, Huihui Ye	2017	63
11	A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer Clinical Cancer Research ·Rana R. McKay, Lillian Werner, Elahe A. Mostaghel, Rosina T. Lis, Olga Voznesensky, Zhenwei Zhang, Brett T. Marck, Alvin M. Matsumoto, Liran Domachevsky, Katherine Zukotynski, Manoj Bhasin, Glenn J. Bubley, Bruce Montgomery, Philip W. Kantoff, Steven P. Balk, Mary‐Ellen Taplin	2016	28
12	PLZF, a Tumor Suppressor Genetically Lost in Metastatic Castration-Resistant Prostate Cancer, Is a Mediator of Resistance to Androgen Deprivation Therapy Cancer Research ·Chen-Lin Hsieh, Ginevra Botta, Shuai Gao, Tiantian Li, Eliezer M. Van Allen, Daniel J. Treacy, Changmeng Cai, Housheng Hansen He, Christopher J. Sweeney, Myles Brown, Steven P. Balk, Peter S. Nelson, Levi A. Garraway, Philip W. Kantoff	2015	46
13	Whole Transcriptome Sequencing Reveals Extensive Unspliced mRNA in Metastatic Castration-Resistant Prostate Cancer Molecular Cancer Research ·Adam G. Sowalsky, Zheng Xia, Liguo Wang, Hao Zhao, Shaoyong Chen, Glenn J. Bubley, Steven P. Balk, Wěi Li	2014	84
14	Rapid Induction of Androgen Receptor Splice Variants by Androgen Deprivation in Prostate Cancer Clinical Cancer Research ·Ziyang Yu, Sen Chen, Adam G. Sowalsky, Olga Voznesensky, Elahe A. Mostaghel, Peter S. Nelson, Changmeng Cai, Steven P. Balk	2014	148
15	PTEN-Deficient Tumors Depend on AKT2 for Maintenance and Survival Cancer Discovery ·Y. Rebecca Chin, Xin Yuan, Steven P. Balk, Alex Toker	2014	74
16	Abiraterone Treatment in Castration-Resistant Prostate Cancer Selects for Progesterone Responsive Mutant Androgen Receptors Clinical Cancer Research ·Eddy J. Chen, Adam G. Sowalsky, Shuai Gao, Changmeng Cai, Olga Voznesensky, Rachel Schaefer, Massimo Loda, Lawrence D. True, Huihui Ye, Patricia Troncoso, Rosina L. Lis, Philip W. Kantoff, Bruce Montgomery, Peter S. Nelson, Glenn J. Bubley, Steven P. Balk, Mary-Ellen Taplin	2014	139
17	Tyrosine Kinase BMX Phosphorylates Phosphotyrosine-Primed Motif Mediating the Activation of Multiple Receptor Tyrosine Kinases Science Signaling ·Sen Chen, Xinnong Jiang, Christina Gewinner, John M. Asara, Nicholas I. Simon, Changmeng Cai, Lewis C. Cantley, Steven P. Balk	2013	18
18	Clonal Progression of Prostate Cancers from Gleason Grade 3 to Grade 4 Cancer Research ·Adam G. Sowalsky, Huihui Ye, Glenn J. Bubley, Steven P. Balk	2012	65
19	Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors Cancer Research ·Changmeng Cai, Sen Chen, Patrick Kwok‐Shing Ng, Glenn J. Bubley, Peter S. Nelson, Elahe A. Mostaghel, Brett T. Marck, Alvin M. Matsumoto, Nicholas I. Simon, Hongyun Wang, Shaoyong Chen, Steven P. Balk	2011	349
20	Reactivation of Androgen Receptor–Regulated TMPRSS2:ERG Gene Expression in Castration-Resistant Prostate Cancer Cancer Research ·Changmeng Cai, Hongyun Wang, Youyuan Xu, Shaoyong Chen, Steven P. Balk	2009	122

About Steven P. Balk

Steven P. Balk is a scholar working on Immunology, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism, Cancer Research and Genetics, having authored 241 papers that have together received 20.9k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (120 papers), Immune Cell Function and Interaction (76 papers), T-cell and B-cell Immunology (57 papers), Hormonal and reproductive studies (43 papers), Estrogen and related hormone effects (35 papers), Immunotherapy and Immune Responses (26 papers), Ubiquitin and proteasome pathways (25 papers) and Cancer, Lipids, and Metabolism (18 papers). The work is most often cited by research in Immunology (7.7k citations), Pulmonary and Respiratory Medicine (7.6k citations), Cancer Research (3.4k citations), Endocrinology, Diabetes and Metabolism (2.7k citations) and Oncology (3.6k citations). Steven P. Balk has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Glenn J. Bubley, Mark A. Exley, Steven A. Porcelli, Mary‐Ellen Taplin, Changmeng Cai, Xin Yuan, Richard S. Blumberg, Shaoyong Chen, Michael B. Brenner and Cox Terhorst. Their work appears in journals such as Cancer Research, The Journal of Immunology, Clinical Cancer Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact